Peru · Delayed Price · Currency is PEN · Price in USD Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of PEN 1.01 trillion. The enterprise value is 1.09 trillion.
| Market Cap | 1.01T |
| Enterprise Value | 1.09T |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Dec 15, 2025 |
Share Statistics
| Current Share Class | 2.48B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.34% |
| Shares Change (QoQ) | -0.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 16.46 and the forward PE ratio is 23.61.
| PE Ratio | 16.46 |
| Forward PE | 23.61 |
| PS Ratio | 4.62 |
| PB Ratio | 5.79 |
| P/TBV Ratio | 20.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.73 |
| EV / Sales | 5.00 |
| EV / EBITDA | 11.29 |
| EV / EBIT | 13.27 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 18.06 |
Financial Efficiency
Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.
| Return on Equity (ROE) | 37.17% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 28.30% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.96M |
| Profits Per Employee | 829,866 |
| Employee Count | 74,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 9.43 billion in taxes.
| Income Tax | 9.43B |
| Effective Tax Rate | 13.31% |
Stock Price Statistics
The stock price has increased by +41.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +41.56% |
| 50-Day Moving Average | 109.20 |
| 200-Day Moving Average | 90.52 |
| Relative Strength Index (RSI) | 84.82 |
| Average Volume (20 Days) | 84 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.03 |
Income Statement
In the last 12 months, Merck & Co. had revenue of PEN 218.71 billion and earned 61.41 billion in profits. Earnings per share was 24.49.
| Revenue | 218.71B |
| Gross Profit | 168.59B |
| Operating Income | 82.44B |
| Pretax Income | 70.87B |
| Net Income | 61.41B |
| EBITDA | 96.88B |
| EBIT | 82.44B |
| Earnings Per Share (EPS) | 24.49 |
Balance Sheet
The company has 61.28 billion in cash and 139.19 billion in debt, with a net cash position of -77.91 billion.
| Cash & Cash Equivalents | 61.28B |
| Total Debt | 139.19B |
| Net Cash | -77.91B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 174.63B |
| Book Value Per Share | 70.13 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.
| Gross Margin | 77.08% |
| Operating Margin | 37.69% |
| Pretax Margin | 32.41% |
| Profit Margin | 28.08% |
| EBITDA Margin | 44.30% |
| EBIT Margin | 37.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.57, which amounts to a dividend yield of 9.56%.
| Dividend Per Share | 11.57 |
| Dividend Yield | 9.56% |
| Dividend Growth (YoY) | -0.89% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.34% |
| Shareholder Yield | 10.90% |
| Earnings Yield | 6.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |